ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HR................................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/01626983CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120101222W172deBibliographieenBibliographyfrBibliographieEP04760997.9200405122005120920060913enenen470246 P20030512US2010122220105120060222200608201008182010332009121820101222201051C07K 14/505 20060101AFI20060324BHEP A61K 47/48 20060101ALI20060324BHEP deNEUE POLY(ETHYLENGLYCOL) MODIFIZIERTE ERYTHROPOIETINAGONISTEN UND DEREN VERWENDUNGENenNOVEL POLY (ETHYLENE GLYCOL) MODIFIED ERYTHROPOIETIN AGONISTS AND USES THEREOFfrNOUVEAUX COMPOSES MODIFIES PAR DU POLY(ETHYLENE GLYCOL) ET LEURS UTILISATIONSEP-A- 0 400 472WO-A-00/12587WO-A-92/1622110173110.720100817HOLMES, Christopher P.13633 Westover DriveSaratoga, CA 95070USTUMELTY, David250 Santa Fe Terrace 106,Sunnyvale, CA 94085USYIN, Qun747 Coastland DrivePalo Alto, CA 94303USAffymax, Inc.100072434DMI/PN756487EP4001 Miranda AvenuePalo Alto, CA 94304USIcely, Dominic Michael101091216Marks & Clerk LLP Oxford Business Park South 4220 Nash CourtOxford OX4 2RUGB010120090401ETakeda Pharmaceutical Company Limited1011046491-1, Doshomachi 4-chome Chuo-kuOsaka 540-08645JPATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLUMCNLPLPTROSESISKTRATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLILUMCNLPLPTROSESISKTRAL20051209HR20051209LT20051209LV20051209MK20051209US200401488820040512enWO200410160020041125200448